Breaking News
Get 50% Off 0
🏄 Grow your portfolio even on vacation with InvestingPro | Summer Sale 50% OFF
CLAIM SALE

Ambar Warrick

Joined: Jul 27, 2022
  • News

Ambar Warrick's News
A complete archive of Ambar Warrick's news items - Page 95

Novartis receives third FDA approval for oral Fabhalta
Novartis receives third FDA approval for oral Fabhalta By Investing.com - Mar 21, 2025

Novartis today announced that oral Fabhalta® (iptacopan) has received U.S. Food and Drug Administration (FDA) approval for the treatment of adults with C3 glomerulopathy (C3G), to...